AI Article Synopsis

  • P-selectin glycoprotein ligand-1 (PSGL-1) on leukocytes interacts with the G3 domain of proteoglycan PG-M/versican, facilitating leukocyte rolling in blood vessels.
  • Cells with PSGL-1, when exposed to versican or its G3 multimers, aggregate, indicating that these multimers form a network that promotes clustering.
  • The presence of G3 fragments in human plasma is crucial for leukocyte aggregation, and these findings were further validated in a mouse model, highlighting the significance of the PSGL-1/versican interaction in immune responses.

Article Abstract

P-selectin glycoprotein ligand-1 (PSGL-1), a glycoprotein expressed on the cell surface of leukocytes, binds to selectins and mediates leukocyte rolling on the vascular endothelium. Here we report that PSGL-1 binds to the C-terminal (G3 domain) of the extracellular proteoglycan PG-M/versican. Cells transfected with PSGL-1 or a shorter form containing the binding site, or cells expressing endogenous PSGL-1 aggregate in the presence of versican or G3 product. The aggregation appears to be induced by G3 multimers that bind to PSGL-1 and form a network. Endogenous versican and/or G3-containing fragments also bind to PSGL-1 in human plasma. Removal of the endogenous G3-containing fragments reduces the effect of plasma on leukocyte aggregation. Finally, the roles of G3-containing fragments in leukocyte aggregation were confirmed in a mouse model. Taken together, our results strongly support a physiologically relevant role for PSGL-1/versican binding and may have implications in the immunoresponse.

Download full-text PDF

Source
http://dx.doi.org/10.1242/jcs.01516DOI Listing

Publication Analysis

Top Keywords

leukocyte aggregation
12
g3-containing fragments
12
p-selectin glycoprotein
8
glycoprotein ligand-1
8
mediates leukocyte
8
bind psgl-1
8
psgl-1
6
pg-m/versican binds
4
binds p-selectin
4
ligand-1 mediates
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!